JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M001007200 on March 20, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/20/15014    most recent
M001007200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wärnmark, A.
Right arrow Articles by Wright, A. P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wärnmark, A.
Right arrow Articles by Wright, A. P. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 20, 15014-15018, May 19, 2000


Architectural Principles for the Structure and Function of the Glucocorticoid Receptor tau 1 Core Activation Domain*

Anette WärnmarkDagger §, Jan-Åke GustafssonDagger , and Anthony P. H. WrightDagger §

From the Dagger  Department of Biosciences, Karolinska Institutet, Novum, Huddinge S-141 57, Sweden and § Södertörns Högskola, Box 4101, Huddinge S-141 04, Sweden

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A 58-amino acid region mediates the core transactivation activity of the glucocorticoid receptor tau 1 activation domain. This tau 1 core domain is unstructured in aqueous buffers, but in the presence of trifluoroethanol three alpha -helical segments are induced. Two of these putative structural modules have been tested in different combinations with regard to transactivation potential in vivo and binding capacity to the coactivators in vitro. The results show that whereas single modules are not transcriptionally active, any combination of two or three modules is sufficient, with trimodular constructs having the highest activity. However, proteins containing one, two, or three segments bind Ada2 and cAMP-response element-binding protein with similar affinity. A single segment is thus able to bind a target factor but cannot transactivate target genes significantly. The results are consistent with models in which activation domains are comprised of short activation modules that allow multiple interactions with coactivators. Our results also suggest that an increased number of modules may not result in correspondingly higher affinity but instead that the concentration of binding sites is increased, which gives rise to a higher association rate. This is consistent with a model where the association rate for activator-target factor interactions rather than the equilibrium constant is the most relevant measure of activator potency.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Transcriptional regulatory proteins are often composed of domains that can function independently of the other parts of the protein. It is generally accepted that these proteins can be subdivided into fully functional DNA-binding domains and activation domains. In the case of activation domains, the concept of modularity has been extended to suggest that these domains are themselves built up of short peptide modules that contribute to gene activation independently of each other but in a synergistic manner (1-5). These ideas lead to the suggestion that even though the subdomains could employ distinct mechanisms, they may be functionally redundant and that it would be the number rather than the composition of the submodules in an activation domain that is of importance for its gene activation potential.

The glucocorticoid receptor (GR)1 belongs to the large family of ligand-inducible nuclear receptors that function by modulating the transcription of target genes (6, 7). The transactivation activity of the human GR is mainly mediated by two domains, tau 1 (residues 77-262), which resides at the N terminus of the protein, and tau 2 (residues 526-556), which is localized just C-terminally of the DNA-binding domain (DBD) (8, 9). A small region at the C terminus of the receptor may also play a role in GR-mediated transcription (10). The tau 1 domain constitutes the major transactivation function in the GR, and this domain represents the only autonomous activation region within the GR N terminus (9). When fused to a DNA-binding domain, tau 1 constitutively activates transcription both in vivo and in vitro (11, 12). A 58-amino acid segment that represents the core activation domain (the tau 1 core) has been localized to residues 187-244 (13). This domain retains 60-70% of the activity conferred by the intact tau 1 domain (13). The tau 1 core domain belongs to the group of acidic activators because of its relative abundance of acidic amino acid residues. Mutagenesis studies of the tau 1 core domain (14) and of acidic activation domains in VP16 (15-17), GCN4 (5, 18), NF-kappa B p65 (2), p53 (19), and HNF-4 (20) have shown that hydrophobic amino acids are important for transactivation activity of both isolated activation domains and intact activator proteins.

Similar to the transactivation domains of VP16 (21, 22) and NF-kappa B p65 (23), purified tau 1 and tau 1 core proteins have been shown to be unstructured in aqueous solution as measured by circular dichroism and NMR spectroscopy (24). However, in trifluoroethanol, the tau 1 core forms alpha -helices, which is also consistent with studies of the VP16 (21) and NF-kappa B p65 (23) transactivation domains. Three putative alpha -helical regions in the tau 1 core have been identified by NMR spectroscopy (25). Proline substitution mutants within two of the putative helical regions reduce the transactivation activity of the tau 1 core and also its ability to form alpha -helices in trifluoroethanol (24). alpha -Helix formation may thus be an important step in tau 1-mediated gene activation, and it is possible that target factor interactions induce or stabilize a structured conformation in the activation domain similar to the situation that has been demonstrated for activation domains of p53 (26) and VP16 (27, 28).

If this model is correct for the tau 1 core, the alpha -helices that can be induced in the tau 1 core peptide can be considered as structural modules. In this study we wanted to further address whether the tau 1 core domain is composed of modules with distinct and independent functions or whether it should be viewed as a structurally integrated protein domain. The results reported here provide evidence for a model in which the tau 1 core activation domain is built up of small modules with acidic and hydrophobic character, each of which interacts with target protein(s) to give efficient activation of transcription. Furthermore, the ability of constructs consisting of duplicated and triplicated modules of the same type to activate transcription suggests that the individual segments do not carry determinants absolutely critical for transactivation function.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Strains and Plasmids

Strains-- The Saccharomyces cerevisiae strain W303-1A (MATa, ade2-1°, can1-100°, his3-11, 15, leu2-3, 112, trp1-1a, ura3-1) was used as the yeast host cell for all experiments in the study. The Escherichia coli strain BL21(DE3)plysS (Novagen) was used for GST and GST fusion protein expression.

Plasmids-- pKVBB-GRDBD-tau 1 core and pKVBB-GRDBD-tau 1-(187-227) express tau 1 core and tau 1-(187-227), respectively, fused to the GR DBD. The plasmid pKVBB-GRDBD was generated from plasmid pKV-XE (11) by destroying the existing BamHI site and inserting a linker containing a BamHI and a BglII site in the SacI site. BamHI-BglII fragments corresponding to tau 1 core-H1 and tau 1 core-H2 were amplified by PCR using the following primers: 5'-CAGCAGGGATCCCCTGACCAAAGCACCTTTGACAT-3' and 5'-CCACCAAGATCTATTCGTCTCTTTACCTGGGG-3' for the H1 fragment and 5'-CAGCAGGGATCCCCTTGGAGATCAGACCTGTTG-3' and 5'-CCACCAAGATCTATTCGTCTCTTTACCAGGAGAAAGCAAACAGTTTTC-3' for the H2 fragment. In this way amino acid sequence GKETN (from the region following the H1 segment) is joined to the end of the H2 module, thus giving a similar linker sequence between any two segments in the different combinations. Plasmid pKVBB-GRDBD expressing GR DBD was cleaved with BamHI and BglII, and the PCR fragments were inserted, resulting in plasmids pKVBB-GRDBD-H1 and pKVBB-GRDBD-H2, respectively. To obtain pKVBB-GRDBD-H1-H1, -H1-H2, -H2-H2, and -H2-H1, pKVBB-GRDBD-H1 and pKVBB-GRDBD-H2 were linearized by BglII, and the BamHI-BglII PCR fragments were inserted. The following trisegment plasmid constructs were made using the same strategy: pKVBB-GRDBD-H1-H1-H1, -H1-H2-H1, -H1-H1-H2, -H2-H1-H1, and -H2-H2-H2. The GR-responsive lacZ reporter gene contains two glucocorticoid response elements from the rat tyrosine aminotransferase promotor cloned upstream of a basal CYC1-lacZ promotor and is contained in the vector pLGZ-2xTAT, described previously (29). GST fusion plasmids pGEX-Ada2 and pGEX-CBP-C2 (amino acids 1678-1868) have been described previously (30).

Transactivation Assay in Yeast

Plasmids were transformed into the yeast strains using a spheroplast procedure (31). Several colonies from each transformation were checked on 5-bromo-4-chloro-3-indolyl-beta -galactopyranoside (X-gal) plates for homogeneity of transactivation activity (32). Representative transformants were grown in minimal medium with 2% glucose for at least 18 h. The cultures were then diluted to an A600 of 0.2 in minimal medium with 3% glycerol and 1% ethanol and grown for 24 h. After 24 h the cultures were diluted to an A600 of 0.2 in minimal medium containing 2% galactose and cultured for an additional 4-5 h. Extracts were prepared and assayed for beta -galactosidase activity as described previously (33).

Western Blot Detection of Proteins in Whole Cell Yeast Extracts

Yeast extracts were prepared using the rapid protein extraction procedure described by Horvath and Riezman (34). The proteins in the extracts were separated by SDS-polyacrylamide gel electrophoresis using 12% polyacrylamide resolving gels and then electrophoretically transferred to Hybond-C membranes at 4 °C (Amersham Pharmacia Biotech) using standard procedures. The membranes were blocked with 5% milk powder in phosphate-buffered saline containing 0.05% Tween 20 (PBS-T) overnight. The membranes were incubated for 60 min at room temperature with a monoclonal antibody raised against GR DNA-binding domain (kindly provided by Ann-Charlotte Wikström and Marika Rönnholm, Department of Medical Nutrition, Karolinska Institutet) in PBS-T. After washing, the membranes were incubated with horseradish peroxidase-linked sheep anti-mouse immunoglobulin G antibody (Amersham Pharmacia Biotech) in PBS-T for 60 min. The membranes were then thoroughly washed and developed using chemiluminescence with an ECL mixture (68 mM p-coumaric acid, 1.25 mM luminol in Tris, pH 8.5, 0.009% H2O2).

Total RNA Isolation and Northern Blotting

Transformant W303-1A cells were grown as described above under "Transactivation Assay in Yeast." Total RNA was prepared as described by Schmitt et al. (35) and then run on denaturing MOPS gels and blotted onto Hybond-N filters (Amersham Pharmacia Biotech) as described in Ref. 36. For prehybridization, hybridization, washing, and detection, the Gene Images CDP-Star detection module (Amersham Pharmacia Biotech) was used according to the manufacturer's instructions. Preparation of fluorescein-labeled probes for hybridization was done using the Gene Images random-prime labeling module (Amersham Pharmacia Biotech) and with a GR-DBD PCR fragment and a HindIII-BamHI actin fragment as templates.

Protein-Protein Interaction Assay

GST and GST fusion proteins were expressed and purified essentially as described previously (30). PCR was run in which the different pKVBB-GRDBD plasmids served as templates and the following primers were used: 5'-CGAATTAACCCTCACTAAAGGGAACGCCGCCAC CATGGTCAATTCGAGCTCAGGATCCCC-3' and 5'-TCAACCATGGTCAATTCCTTTTAT-3'. [35S]Methionine-labeled proteins were generated by in vitro transcription/translation of the PCR products containing a 5'-T3 promotor using a TNT kit (Promega) at 30 °C for 90 min. The in vitro translated proteins were incubated with approximately 1 µg of glutathione-Sepharose-bound GST proteins in 200 µl of pull-down buffer (20 mM HEPES (pH 7.9), 10% (v/v) glycerol, 100 mM KCl, 0.2 mM EDTA, 5 mM MgCl2, 0.2 mM phenylmethanesulfonyl fluoride, 1 mM dithiothreitol) also containing Nonidet P-40 and bovine serum albumin to total concentrations of 0.01% (v/v) and 1.5% (w/v), respectively. Incubation with rotation was carried out at 4 °C for 2 h. Beads were collected by centrifugation and washed three times with 400 µl of pull-down buffer by rotating 15 min at 4 °C. Washed beads were resuspended in 20 µl of 1 × SDS sample buffer, boiled for 10 min, and pelleted in a microcentrifuge. 10 µl of supernatant was subjected to SDS-polyacrylamide gel electrophoresis (15% polyacrylamide resolving gel). To monitor the stability and equal loading of the GST fusion proteins, gels were stained with Coomassie Blue before autoradiography.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

H1 and H2 Segments Function as Interchangeable Modules That Contribute Synergistically to Gene Activation-- A schematic representation of the tau 1 core transactivation domain of human GR is shown in Fig. 1A. The location of segments with propensity for alpha -helical formation as identified by NMR is also shown. The amino acid sequences of the tau 1 core, tau 1-(187-227), H1, and H2 are shown in Fig. 1B.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Domain structure of GR and amino acid sequences of the tau 1 fragments used. A, schematic representation of the human glucocorticoid receptor. tau 1 and tau 2 transactivation domains, the DBD, and the steroid-binding domain (SBD) of the GR are indicated. The tau 1 core is indicated by a shaded box. The locations of segments with propensity for alpha -helical conformation identified by NMR are shown as cylinders. B, the amino acid sequence of the tau 1 core, tau 1-(187-227), H1, and H2. The BamHI site in the single H1 and H2 constructs gives rise to amino acids Gly and Ser in the H1 and H2 proteins, whereas the BglII/BamHI site that connects the different H1 and H2 modules in the other constructs gives rise to amino acids Arg and Ser.

To investigate whether the putative helical segments in the tau 1 core are interchangeable and to see how the transactivation activity is affected by both the order and number of segments, different combinations of H1 and H2 were fused to the GR DBD (Fig. 2). Previous mutagenesis and deletion studies (13, 14) of the tau 1 core domain have indicated a less important role for H3 compared with H1 and H2. Because of this and for practical reasons in the experimental design, the H1 and H2 segments were used in this study. The different proteins were expressed in yeast cells in which expression of beta -galactosidase is controlled by two glucocorticoid-responsive elements. The beta -galactosidase data obtained from yeast strain W303-1A (Fig. 2) show that one segment only is not enough for significant activation but that any combination of two segments is sufficient to give transcriptional activation. The level of activation achieved with two segments is lower than for tau 1-(187-227) but still significant. Constructs containing three segments showed a transactivation potential comparable with the wild type tau 1 core. The exceptions are constructs containing only one type of module, i.e. the H1-H1-H1 and H2-H2-H2 proteins, which both had a lower transactivation activity than did the wild type tau 1 core. By these criteria, the H1 and H2 segments appear to function as interchangeable modules that contribute synergistically to gene activation. However, to be able to draw firm conclusions from the transactivation activity data, the expression levels of the different proteins were analyzed by Western blotting using an antibody against GR DBD. Data in Fig. 3 show protein levels to be very similar except for constructs containing only H1 segments, which were expressed at a much lower level. With longer exposure times, however, bands of the predicted size of H1, H1-H1, and H1-H1-H1 could be detected (data not shown).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Transactivation potential of the tau 1 core, tau 1-(187-227), and different H1 and H2 combinations in yeast cells. All activities were normalized to that of the tau 1 core. The results represent mean values (± S.D.) obtained from at least three independent experiments for each construct tested.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 3.   Immunoblot analysis of expression levels of the tau 1 core, tau 1-(187-227), and different H1 and H2 combinations. Aliquots containing equivalent amounts of protein from whole cell yeast extracts were separated by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose filters. The GR DBD fusion proteins were detected with an antibody against GR DBD.

Low Expression of Constructs Containing Only H1 Modules Is Not Due to Differences at the mRNA Level-- Because gene expression is often regulated at the level of transcription, it is necessary to investigate whether the observed differences in protein levels are due to differences at the mRNA level. The transcript levels of selected constructs were assayed by Northern blotting of total RNA extracted from W303-1A yeast cells expressing the corresponding constructs using probes that hybridize to GR DBD and actin (internal control) mRNA. The results show that very similar amounts of mRNA were produced by the different constructs (Fig. 4). Consequently, the differences seen in protein expression levels for the H1, H1-H1, and H1-H1-H1 constructs cannot be accounted for by differences at the level of transcription but must originate at the level of protein synthesis or protein stability.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 4.   Northern blot analysis of mRNA levels in yeast strains expressing H1 and H2 fusion proteins. Total RNA was extracted from W303-1A yeast cells expressing each of the tested constructs. The mRNA transcripts were detected using probes that hybridize to GR DBD or actin (internal control) mRNA.

Binding of Cofactors Ada2 and CBP to Mono-, Di-, and Trimodular Constructs-- Ada2 and CBP proteins are coactivators known to bind to the tau 1 core (30, 37). To test whether the binding capacity of the tau 1 core to coactivators correlates with the demonstrated transcriptional activity, an in vitro protein-protein interaction assay was performed using GST-Ada2 and GST-CBP-C2 fusion proteins and the [35S]methionine-labeled in vitro translated tau 1 core and different H segment proteins. As shown in Fig. 5A, proteins containing one, two, or three H2 segments resulted in similar binding to both Ada2 and CBP-C2, but no binding to GST alone was seen. Furthermore, several constructs containing combinations of H1 and H2 modules did not show significantly higher binding affinity (Fig. 5B). The tau 1 core included in the experiment as a control showed a similar binding affinity to that of the other constructs. Thus, the substantially higher activity seen in the transactivation experiments for the multisegment constructs is not due to a dramatically higher affinity for target factor binding.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 5.   Protein-protein interactions of the tau 1 core and different H1 and H2 combinations with Ada2 and CBP-C2. Binding of the [35S]methionine-labeled in vitro translated tau 1 core or different H1 and H2 combinations to GST, GST-Ada2, or GST-CBP-C2. The input lanes represent 10% of the amount of labeled protein used in each pull-down. A, the effect of the number of H2 segments is shown. B, the effect of including H1 in different combinations with H2 is shown.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The tau 1 core activation domain of GR contains three putative alpha -helical structural segments (25) that have been shown previously to have an important role in the transcriptional activation function of the GR receptor (30). In this study we have used a hybrid protein approach involving different combinations of the H1 and H2 activation submodules of the tau 1 core to analyze the functional dependence on the modular structure. The purpose of the study was to address whether the tau 1 core region should be viewed as a structurally integrated domain or as composed of redundant submodules. We have demonstrated that isolated H1 and H2 segments do not have significant residual activities on their own (Fig. 2). We have further shown that duplication of H1 and H2 segments in different combinations is sufficient for transcriptional activation. Results obtained with the duplication constructs also showed that neither segment carries unique determinants absolutely critical for transactivation function. In addition, trimodular constructs gave rise to higher transactivation activity than the duplication constructs, reaching levels comparable with the wild type tau 1 core. These results support the model, mentioned in the introduction, in which activation domains are composed of short, partly redundant modules (1-5).

Aromatic and hydrophobic amino acids are known to be important for activity, as indicated by mutagenesis studies of acidic domains of GR (14), VP16 (15-17), NF-kappa B p65 (2), and HNF-4 (20). Furthermore, alpha -helical structure formation of acidic activator domains upon binding to putative target factors has been demonstrated in circular dichroism studies of the c-Myc activation domain bound to TATA-binding protein (38), crystal structure studies of the p53 activation domain bound to MDM2 (26), fluorescence analyses of the interaction of the VP16 activator domain with TATA-binding protein (27), and NMR studies of the VP16 activator domain upon interaction with TAF31 (28). These studies are consistent with an induced fit model for the folding of an otherwise unstructured activator domain. These findings together with the ability of the H1-only or H2-only proteins (e.g. H1-H1 and H2-H2) to activate transcription, shown here, suggest that secondary structure formation and/or formation of hydrophobic surfaces are likely to be more important for transcriptional activation than the primary amino acid sequence as such. However, our study also indicates that the two modules H1 and H2 are functionally distinct, at least in part. First, combinations of H1 and H2 are always better activators than H1-only or H2-only alternatives. Second, the H2 module has a positive effect on the protein levels of the constructs in which it is contained. Presumably, it either facilitates production or perhaps more likely stabilizes these proteins. In addition, H1 may have higher activation potential than H2 because a comparably high transactivation was observed for the relatively low protein levels of the H1-only constructs.

Previous studies have shown an exquisite proportionality between binding affinity and transcription potential for different tau 1 core amino acid substitution mutants (30). It was therefore important to show whether this is also true for the constructs described here, which differ widely in activity. The results show that the different constructs bind each target factor, Ada2 or CBP, with similar affinity (Fig. 5). The dramatically higher transactivation observed for the trimodular constructs (of different combinations) compared with the mono-modular constructs is therefore not due to an increased overall binding affinity to target factors. Thus, large deletions in the tau 1 core do not change target factor binding affinity but severely affect transactivation potential so that the previously observed proportionality between binding affinity and transactivation activity is lost. An explanation probably lies in the fact that the number of binding modules was kept constant in the previous study (with the full-length tau 1 core) whereas it was varied in the present study.

It has been shown that different components of the transcription initiation complex (e.g. TATA-binding protein, Ada2, and CBP) are able to bind to the tau 1 core domain (30, 37, 39). That several transcription factors and coactivators are molecular targets for acidic activators has also been shown for activators such as VP16, NF-kappa B p65, and HNF-4. Examples of targets include TATA-binding protein, TFIIB, TAFII31, TAFII80, CBP, Ada2, and PC4 (20, 40-42). Protein-protein in vitro interaction assays monitor binding affinity for one target factor at a time, whereas transactivation assays measure transcription activity in vivo where many different target factors/coactivators are present. Our results could therefore imply that multiple interactions are required for efficient transactivation. The stoichiometry of the binding of the tau 1 core to target proteins has not been determined. The presence of multiple redundant modules would also increase the concentration of binding sites that can interact with the target factors and thereby give rise to a higher association rate. The requirement for multiple modules, as demonstrated in this study, thus suggests that the modular architecture of the activation domain may underlie its ability to activate gene transcription by influencing the kinetics through changes in association rate of its interaction with one or more target factors. This model would be consistent with our previous results showing proportionality between activation potential and binding affinity in tau 1 core mutants if the affinity changes observed for these mutants are also accompanied by changes in target factor interaction kinetics. In the future, direct association and dissociation measurements have to be made to test this model.

The similar properties in terms of hydrophobicity, acidic amino acid content, propensity for alpha -helical formation, and modular structure of the tau 1 core and other acidic activation domains could reflect a general mechanism for such activators, which would involve complex and dynamic interactions with different target factors acting synergistically to achieve efficient activation of transcription.

    ACKNOWLEDGEMENTS

We thank members of the Steroid Receptor Unit at the Department of Biosciences for helpful comments during this work, Stefan Hermann and Tova Almlöf for fruitful discussions, and Ann-Charlotte Wikström and Marika Rönnholm for generously providing the monoclonal antibody against GR DBD.

    FOOTNOTES

* This work was supported by Swedish Natural Sciences Research Council Grants KU9756 and LS9756 and Swedish Medical Research Council Grant 13x-2819.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 46 8 608 91 55; Fax: 46 8 774 55 38; E-mail: anette.warnmark@cbt.ki.se.

Published, JBC Papers in Press, March 20, 2000, DOI 10.1074/jbc.M001007200

    ABBREVIATIONS

The abbreviations used are: GR, glucocorticoid receptor; DBD, DNA-binding domain; GST, glutathione S-transferase; PCR, polymerase chain reaction; CBP, cAMP-response element-binding protein; MOPS, 4-morpholinepropanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Sutherland, J. A., Cook, A., Bannister, A. J., and Kouzarides, T. (1992) Genes Dev. 6, 1810-1819
2. Blair, W. S., Bogerd, H. P., Madore, S. J., and Cullen, B. R. (1994) Mol. Cell. Biol. 14, 7226-7234
3. Nerlov, C., and Ziff, E. B. (1994) Genes Dev. 8, 350-362
4. Nerlov, C., and Ziff, E. B. (1995) EMBO J. 14, 4318-4328
5. Jackson, B. M., Drysdale, C. M., Natarajan, K., and Hinnebusch, A. G. (1996) Mol. Cell. Biol. 16, 5557-5571
6. Beato, M., Herrlich, P., and Schutz, G. (1995) Cell 83, 851-857
7. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. M. (1995) Cell 83, 835-839
8. Giguere, V., Hollenberg, S. M., Rosenfeld, M. G., and Evans, R. M. (1986) Cell 46, 645-652
9. Hollenberg, S. M., and Evans, R. M. (1988) Cell 55, 899-906
10. Danielian, P. S., White, R., Lees, J. A., and Parker, M. G. (1992) EMBO J. 11, 1025-1033
11. Wright, A. P., McEwan, I. J., Dahlman-Wright, K., and Gustafsson, J. A. (1991) Mol. Endocrinol. 5, 1366-1372
12. McEwan, I. J., Wright, A. P., Dahlman-Wright, K., Carlstedt-Duke, J., and Gustafsson, J. A. (1993) Mol. Cell. Biol. 13, 399-407
13. Dahlman-Wright, K., Almlöf, T., McEwan, I. J., Gustafsson, J. A., and Wright, A. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1619-1623
14. Almlöf, T., Gustafsson, J. A., and Wright, A. P. (1997) Mol. Cell. Biol. 17, 934-945
15. Cress, W. D., and Triezenberg, S. J. (1991) Science 251, 87-90
16. Regier, J. L., Shen, F., and Triezenberg, S. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 883-887
17. Sullivan, S. M., Horn, P. J., Olson, V. A., Koop, A. H., Niu, W., Ebright, R. H., and Triezenberg, S. J. (1998) Nucleic Acids Res. 26, 4487-4496
18. Drysdale, C. M., Duenas, E., Jackson, B. M., Reusser, U., Braus, G. H., and Hinnebusch, A. G. (1995) Mol. Cell. Biol. 15, 1220-1233
19. Lin, J., Chen, J., Elenbaas, B., and Levine, A. J. (1994) Genes Dev. 8, 1235-1246
20. Green, V. J., Kokkotou, E., and Ladias, J. A. (1998) J. Biol. Chem. 273, 29950-29957
21. Donaldson, L., and Capone, J. P. (1992) J. Biol. Chem. 267, 1411-1414
22. O'Hare, P., and Williams, G. (1992) Biochemistry 31, 4150-4156
23. Schmitz, M. L., dos Santos Silva, M. A., Altmann, H., Czisch, M., Holak, T. A., and Baeuerle, P. A. (1994) J. Biol. Chem. 269, 25613-25620
24. Dahlman-Wright, K., and McEwan, I. J. (1996) Biochemistry 35, 1323-1327
25. Dahlman-Wright, K., Baumann, H., McEwan, I. J., Almlöf, T., Wright, A. P., Gustafsson, J. A., and Hard, T. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1699-1703
26. Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., and Pavletich, N. P. (1996) Science 274, 948-953
27. Shen, F., Triezenberg, S. J., Hensley, P., Porter, D., and Knutson, J. R. (1996) J. Biol. Chem. 271, 4827-4837
28. Uesugi, M., Nyanguile, O., Lu, H., Levine, A. J., and Verdine, G. L. (1997) Science 277, 1310-1313
29. Wright, A. P., and Gustafsson, J. A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 8283-8287
30. Almlöf, T., Wallberg, A. E., Gustafsson, J. A., and Wright, A. P. (1998) Biochemistry 37, 9586-9594
31. Beggs, J. D. (1978) Nature 275, 104-109
32. Bohen, S. P., and Yamamoto, K. R. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11424-11428
33. Wright, A. P., Carlstedt-Duke, J., and Gustafsson, J. A. (1990) J. Biol. Chem. 265, 14763-14769
34. Horvath, A., and Riezman, H. (1994) Yeast 10, 1305-1310
35. Schmitt, M. E., Brown, T. A., and Trumpower, B. L. (1990) Nucleic Acids Res. 18, 3091-3092
36. Brown, T. (1994) in Current Protocols in Molecular Biology (Ausubel, F. M. , Brent, R. , Kingston, R. E. , Moore, D. D. , Seidman, J. G. , Smith, J. A. , and Struhl, K., eds), Vol. 1 , pp. 4.9.1-4.9.14, John Wiley & Sons, Inc., New York
37. Henriksson, A., Almlöf, T., Ford, J., McEwan, I. J., Gustafsson, J. A., and Wright, A. P. (1997) Mol. Cell. Biol. 17, 3065-3073
38. McEwan, I. J., Dahlman-Wright, K., Ford, J., and Wright, A. P. (1996) Biochemistry 35, 9584-9593
39. Ford, J., McEwan, I. J., Wright, A. P., and Gustafsson, J. A. (1997) Mol. Endocrinol. 11, 1467-1475
40. Stringer, K. F., Ingles, C. J., and Greenblatt, J. (1990) Nature 345, 783-786
41. Lin, Y. S., Ha, I., Maldonado, E., Reinberg, D., and Green, M. R. (1991) Nature 353, 569-571
42. Triezenberg, S. J. (1995) Curr. Opin. Genet. Dev. 5, 190-196


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
E. Estebanez-Perpina, L. A. Arnold, N. Jouravel, M. Togashi, J. Blethrow, E. Mar, P. Nguyen, K. J. Phillips, J. D. Baxter, P. Webb, et al.
Structural Insight into the Mode of Action of a Direct Inhibitor of Coregulator Binding to the Thyroid Hormone Receptor
Mol. Endocrinol., December 1, 2007; 21(12): 2919 - 2928.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Callewaert, N. Van Tilborgh, and F. Claessens
Interplay between Two Hormone-Independent Activation Domains in the Androgen Receptor
Cancer Res., January 1, 2006; 66(1): 543 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Friedman, H. Khanna, P. K. Swain, R. DeNicola, H. Cheng, K. P. Mitton, C. H. Weber, D. Hicks, and A. Swaroop
The Minimal Transactivation Domain of the Basic Motif-Leucine Zipper Transcription Factor NRL Interacts with TATA-binding Protein
J. Biol. Chem., November 5, 2004; 279(45): 47233 - 47241.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. U. DE MARTINO, S. ALESCI, G. P. CHROUSOS, and T. KINO
Interaction of the Glucocorticoid Receptor and the Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII): Implications for the Actions of Glucocorticoids on Glucose, Lipoprotein, and Xenobiotic Metabolism
Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 72 - 85.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Warnmark, E. Treuter, A. P. H. Wright, and J.-A. Gustafsson
Activation Functions 1 and 2 of Nuclear Receptors: Molecular Strategies for Transcriptional Activation
Mol. Endocrinol., October 1, 2003; 17(10): 1901 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Kumar and E. B. Thompson
Transactivation Functions of the N-Terminal Domains of Nuclear Hormone Receptors: Protein Folding and Coactivator Interactions
Mol. Endocrinol., January 1, 2003; 17(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hermann, K. D. Berndt, and A. P. Wright
How Transcriptional Activators Bind Target Proteins
J. Biol. Chem., October 19, 2001; 276(43): 40127 - 40132.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M.-C. Zennaro, A. Souque, S. Viengchareun, E. Poisson, and M. Lombes
A New Human MR Splice Variant Is a Ligand-Independent Transactivator Modulating Corticosteroid Action
Mol. Endocrinol., September 1, 2001; 15(9): 1586 - 1598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Kumar, J. C. Lee, D. W. Bolen, and E. B. Thompson
The Conformation of the Glucocorticoid Receptor AF1/tau1 Domain Induced by Osmolyte Binds Co-regulatory Proteins
J. Biol. Chem., May 18, 2001; 276(21): 18146 - 18152.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/20/15014    most recent
M001007200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wärnmark, A.
Right arrow Articles by Wright, A. P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wärnmark, A.
Right arrow Articles by Wright, A. P. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.